We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SERV:NASDAQServe Robotics Inc. Analysis

Data as of 2026-04-30 - not real-time

$8.99

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Serve Robotics is trading at $8.99, comfortably above the computed support of $7.80 but well below the resistance near $10.47. The 20‑day SMA sits below the 50‑day SMA, which in turn lags the 200‑day SMA, confirming the “bearish” trend direction flagged by the model. Nevertheless, the MACD line is crossing above its signal line and the histogram is positive, providing a modest bullish signal that aligns with the recent increase in trading volume. Momentum is neutral, with an RSI of 47 indicating neither overbought nor oversold conditions. Volatility is extreme at roughly 70 % over the past 30 days and the beta of over 4 points to a stock that moves dramatically with the market. Fundamentals are weak: revenue is only $2.6 million with a 4 % growth rate, while operating margins are deeply negative and cash burn exceeds $80 million. The company carries a modest debt load but its cash balance of $233 million provides a limited runway despite negative free cash flow. Analysts have issued a “strong buy” consensus and the mean target price of $18.25 implies more than 100 % upside, a figure echoed by the calculated upside/downside metric. Recent material news highlights the launch of “Maggie,” an AI‑powered conversational robot enabled by 5G edge connectivity, which could expand the firm’s service offering and improve unit economics.
However, the stock has suffered a 56 % max drawdown and appears on high‑risk watchlists, while prominent commentators have warned investors to stay cautious. The combination of high beta, extreme volatility, negative earnings and substantial cash burn pushes the overall risk rating toward the high end of the scale. Given these dynamics, a short‑term hold with a bias toward a cautious buy on dips is prudent, while medium‑term positioning may lean toward a modest buy to capture the upside potential tied to the new product rollout. Over the long horizon the fundamental deficits and regulatory uncertainty in autonomous delivery suggest a defensive stance, limiting exposure unless the company can demonstrate sustainable profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support level
  • positive MACD crossover
  • launch of Maggie AI conversational robot

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • analyst strong_buy consensus with high target price
  • potential >100% upside per target price
  • new AI‑enabled robot expected to drive revenue growth

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • persistent cash burn and negative margins
  • high volatility and beta indicating market sensitivity
  • regulatory and operational uncertainty in autonomous delivery

Key Metrics & Analysis

Financial Health

Revenue Growth401.10%
P/E Ratio-5.6
ROE-42.02%
ROA-27.44%
Debt/Equity1.50
P/B Ratio1.9
Op. Cash Flow$-80241000
Free Cash Flow$-77640496
Industry P/E30.6

Technical Analysis

TrendBearish
RSI47.2
Support$7.80
Resistance$10.47
MA 20$9.02
MA 50$9.29
MA 200$11.07
MACDBullish
VolumeIncreasing
Fear & Greed Index88.55

Valuation

Target Price$18.25
Upside/Downside103.00%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta4.07
Volatility69.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.